These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8100196)

  • 1. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
    Gu XF; Azmitia EC
    Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
    Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
    Azmitia EC; Murphy RB; Whitaker-Azmitia PM
    Brain Res; 1990 Feb; 510(1):97-103. PubMed ID: 1969761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Gudelsky GA; Nash JF
    J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of p-chloroamphetamine neurotoxicity.
    Sprague JE; Johnson MP; Schmidt CJ; Nichols DE
    Biochem Pharmacol; 1996 Oct; 52(8):1271-7. PubMed ID: 8937435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP; Conarty PF; Nichols DE
    Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Eur J Pharmacol; 1999 Dec; 385(2-3):103-10. PubMed ID: 10607865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin regulates osteoclast differentiation through its transporter.
    Battaglino R; Fu J; Späte U; Ersoy U; Joe M; Sedaghat L; Stashenko P
    J Bone Miner Res; 2004 Sep; 19(9):1420-31. PubMed ID: 15312242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells.
    Popova D; Forsblad A; Hashemian S; Jacobsson SO
    PLoS One; 2016; 11(11):e0166750. PubMed ID: 27861613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.